Show Parent

July

Community-acquired pneumonia guidelines: much guidance, but not much evidence Woodhead M. Eur Respir J 2002; 20: 1-3
Respiratory rehabilitation: improvement of short- and long-term outcome Gosselink R. Eur Respir J 2002; 20: 4-5
The lung and carbon dioxide: implications for permissive and therapeutic hypercapnia Kregenow D.A., Swenson E.R. Eur Respir J 2002; 20: 6-11
Interval training as an alternative modality to continuous exercise in patients with COPD Vogiatzis I., Nanas S., Roussos C. Eur Respir J 2002; 20: 12-19
The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease Brooks D., Krip B., Mangovski-Alzamor... S., Goldstein R.S. Eur Respir J 2002; 20: 20-29
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation Cano N.J.M., Roth H., Court-Fortune I., Cynober L., Gerard-Boncompain M., Cuvelier A., Laaban J-P., Melchior J-C., Pichard C., Raphael J-C., Pison C.M. Eur Respir J 2002; 20: 30-37
Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Ringbaek T.J., Viskum K., Lange P. Eur Respir J 2002; 20: 38-42
NOS and COX isoforms and abnormal microvessel responses to CO2 and H in hyperoxia-injured lungs Naoki K., Kudo H., Suzuki K., Takeshita K., Miyao N., Ishii M., Sato N., Suzuki Y., Tsumura H., Yamaguchi K. Eur Respir J 2002; 20: 43-51
Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes Jiang B.H., Maruyama J., Yokochi A., Amano H., Mitani Y., Maruyama K. Eur Respir J 2002; 20: 52-58
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis Humbert M., Labrune P., Sitbon O., Le Gall C., Callebert J., Herve P., Samuel D., Machado R., Trembath R., Drouet L., Launay J-M., Simonneau G. Eur Respir J 2002; 20: 59-65
Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma Bacci E., Di Franco A., Bartoli M.L., Carnevali S., Cianchetti S., Dente F.L., Giannini D., Vagaggini B., Ruocco L., Paggiaro P.L. Eur Respir J 2002; 20: 66-72
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Buhl R., Soler M., Matz J., Townley R., O'Brien J., Noga O., Champain K., Fox H., Thirlwell J., Della Cioppa G. Eur Respir J 2002; 20: 73-78
Association of asthma and total IgE levels with human leucocyte antigen-DR in patients with grass allergy Woszczek G., Kowalski M.L., Borowiec M. Eur Respir J 2002; 20: 79-85
Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking Miller M.R., Sigsgaard T., Omland O., Pedersen O.F. Eur Respir J 2002; 20: 86-91
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Zetterquist W., Marteus H., Johannesson M., Nordvall S.L., Ihre E., Lundberg J.O.N., Alving K. Eur Respir J 2002; 20: 92-99
Nitric oxide but not carbon monoxide is continuously released in the human nasal airways Lundberg J.O.N., Palm J., Alving K. Eur Respir J 2002; 20: 100-103
The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children Peroni D.G., Piacentini G.L., Pietrobelli A., Loiacono A., De Gasperi W., Sabbion A., Micciolo R., Boner A.L. Eur Respir J 2002; 20: 104-107
Relationship between exhaled air temperature and exhaled nitric oxide in childhood asthma Piacentini G.L., Bodini A., Zerman L., Costella S., Zanolla L., Peroni D.G., Boner A.L. Eur Respir J 2002; 20: 108-111
Effects of tracheotomy on respiratory mechanics in spontaneously breathing patients Moscovici da Cruz V., Demarzo S.E., Sobrinho J.B.B., Amato M.B.P., Kowalski L.P., Deheinzelin D. Eur Respir J 2002; 20: 112-117
Endobronchial ultrasound in therapeutic bronchoscopy Herth F., Becker H.D., LoCicero J., Ernst A. Eur Respir J 2002; 20: 118-121
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Nikolaizik W.H., Trociewicz K., Ratjen F. Eur Respir J 2002; 20: 122-126
Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Skov M., Main K.M., Sillesen I.B., Muller J., Koch C., Lanng S. Eur Respir J 2002; 20: 127-133
The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis McKone E.F., Barry S.C., FitzGerald M.X., Gallagher C.G. Eur Respir J 2002; 20: 134-142
MRI of the pharynx and treatment efficacy of a mandibular advancement device in obstructive sleep apnoea syndrome Sanner B.M., Heise M., Knoben B., Machnick M., Laufer U., Kikuth R., Zidek W., Hellmich B. Eur Respir J 2002; 20: 143-150
Exacerbation of sleep-apnoea related nocturnal blood-pressure fluctuations in hypertensive subjects Planes C., Leroy M., Fayet G., Aegerter P., Foucher A., Raffestin B. Eur Respir J 2002; 20: 151-157
Biochemical markers of cerebrovascular injury in sleep apnoea syndrome Jordan W., Hagedohm J., Wiltfang J., Laier-Groeneveld G., Tumani H., Rodenbeck A., Ruther E., Hajak G. Eur Respir J 2002; 20: 158-164
Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection? Elssner A., Jaumann F., Wolf W-P., Schwaiblmair M., Behr J., Furst H., Reichenspurner H., Briegel J., Niedermeyer J., Vogelmeier C. Eur Respir J 2002; 20: 165-169
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Zheng L., Lam W.K., Tipoe G.L., Shum I.H., Yan C., Leung R., Sun J., Ooi G.C., Tsang K.W. Eur Respir J 2002; 20: 170-176
Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice Bailey T.C., Cavanagh C., Mehta S., Lewis J.F., Veldhuizen R.A.W. Eur Respir J 2002; 20: 177-182
Efficiency of cold passover and heated humidification under continuous positive airway pressure Randerath W.J., Meier J., Genger H., Domanski U., Ruhle K-H. Eur Respir J 2002; 20: 183-186
Negative-pressure ventilation: is there still a role? Corrado A., Gorini M. Eur Respir J 2002; 20: 1877
The public health relevance of air pollution abatement Kunzli N. Eur Respir J 2002; 20: 198-209
Activation of second messenger pathways in alveolar macrophages by endotoxin Monick M.M., Hunninghake G.W. Eur Respir J 2002; 20: 210-222
Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Members of the Task Force, Baraldi E., de Jongste J.C., Gaston B., Alving K., Barnes P.J., Bisgaard H., Bush A., Gaultier C., Grasemann H., Hunt J.F., Kissoon N., Piacentini G.L., Ratjen F., Silkoff P., Stick S. Eur Respir J 2002; 20: 223-237
A patient with right upper quadrant abdominal pain, hypotension and dyspnoea Wang P-W., Kuo P-H., Chang Y-C., Yang P-C. Eur Respir J 2002; 20: 238-241
International approaches to the prescription of long-term oxygen therapy Tor M., Turker H. Eur Respir J 2002; 20: 242
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Miravitlles M. Eur Respir J 2002; 20: 243-244
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. R. Aalbers, J. Ayres, V. Backer, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, G.W. Sybrecht. Eur Respir J 2002; 20: 245